Clinical trials inappropriately excluding people of African/Middle Eastern descent, new research shows
Many clinical trials of new cancer drugs may be inappropriately excluding some people with “Duffy-null phenotype,” a trait found predominantly in people of African or Middle Eastern descent, researchers at Dana-Farber Cancer Institute and Queen Mary University of London report in a new study. The Duffy-null phenotype results in relatively lower levels of white blood … Read more
